get a key
steadybase-$ company URGN
account_id none on file
legal_name UroGen Pharma Ltd.
ticker URGN
cik 1668243
domain urogen.com
entry_point_account_id none on file
exchange Nasdaq
sector Health Care
calls 3 filings 0 executives 8 family 0
why_nownone on file
calls
Obviously, we'll build in launch expenses, but the synergies for meetings, for conferences, for other events, for the overlap and the targets, I don't see a significant expansion in the field because of the overlap in the targets. We will adequately prepare for a strong launch with 102. But yes, there are significant synergies that we can take from gel mito.

Aug 10, 2023 / receipt, needs a key / Jeff Bova, Chief Commercial Officer | earnings call 2023-08-10 | transcript 633bdc51-1265-4326-8383-d9d5c97d0ca7 | chars 20488-20848 | segment 21

To underscore this point even further, field-related travel and entertainment expenses were up 15-fold from January to February, and we saw another four-fold jump from February to March. Our ability to have meetings in offices and conduct live speaker programs played an important role in our strong finish to the first quarter and the great start we had to Q2.

May 13, 2021 / receipt, needs a key / Jeff, Chief Commercial Officer | earnings call 2021-05-13 | transcript c5b8d162-0d1d-4baf-b5a8-5817625f7fc6 | chars 11097-11458 | segment 11

And as it relates to spending quarter of a quarter for the year, I think, you know, you saw Q1 was a little bit lower largely because of COVID, some T&E commercial spends.

May 13, 2021 / receipt, needs a key / Molly, other | earnings call 2021-05-13 | transcript c5b8d162-0d1d-4baf-b5a8-5817625f7fc6 | chars 37492-37663 | segment 38

filingsnone on file
executives
Christopher Degnan Chief Financial Officer - receipt
Don Kim CFO - receipt
Dong (Don) Kim Chief Financial Officer - receipt
Jeff Bova Chief Commercial Officer - receipt
Liz Barrett CEO - receipt
Mark Schoenberg Chief Medical Officer - receipt
Mollie Henderson Chief Financial Officer - receipt
Molly Henderson Chief Financial Officer - receipt
familynone on file
upcoming
2026-11-05 earnings call scheduled ir
changes
2024-10-09 Chief Financial Officer, appointed sec_8k
2022-03-21 Chief Financial Officer, appointed sec_8k
2020-09-09 Chief Financial Officer, appointed sec_8k
mcp_package_hint
steadybase-$